• Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

3393 Total Publications

Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.
Shaffer, J. L., Petrella, J. R., Sheldon, F. C., Choudhury, K. R., Calhoun, V. D., Coleman, R. E., & Doraiswamy, P. M.
2013; Journal Radiology; vol. 266; no. 2; pp. 583-591; doi:10.1148/radiol.12120010
Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI.
Toledo, J. B., Xie, S. X., Trojanowski, J. Q., & Shaw, L. M.
2013; Journal Acta Neuropathologica; vol. 126; no. 5; pp. 659-70; doi:10.1007/s00401-013-1151-4
Diagnostic accuracy of markers for prodromal Alzheimer’s disease in independent clinical series.
Prestia, A., Caroli, A., Herholz, K., Reiman, E., Chen, K., Jagust, W. J., & Frisoni, G. B.
2013; Journal Alzheimer's and Dementia; vol. 9; no. 6; pp. 677-86; doi:10.1016/j.jalz.2012.09.016
Effect of cognitive reserve markers on Alzheimer pathologic progression.
Lo, R. Y., & Jagust, W. J.
2013; Journal Alzheimer's Disease and Associated Disorders; vol. 27; pp. 343-350; doi:10.1097/WAD.0b013e3182900b2b
Improving the convergence rate in affine registration of PET and SPECT brain images using histogram equalization.
Salas-Gonzalez, D., Górriz, J. M., Ramírez, J., Padilla, P., & Illán, I. A.
2013; Journal Computational and Mathematical Methods in Medicine; vol. 760903; doi:10.1155/2013/760903
Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease.
Guo, L.-H., Alexopoulos, P., & Perneczky, R.
2013; Journal European Archives of Psychiatry and Clinical Neuroscience; vol. 263; no. 7; pp. 553-60; doi:10.1007/s00406-013-0405-4
Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET.
Shokouhi, S., Claassen, D., Kang, H., Ding, Z., Rogers, B., Mishra, A., & Riddle, W. R.
2013; Journal Journal of Nuclear Medicine; vol. 54; no. 9; pp. 1564-9; doi:10.2967/jnumed.112.116137
Integrative genomics identifies APOE ε4 effectors in Alzheimer’s disease.
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A.
2013; Journal Nature; vol. 500; no. 7460; pp. 45-50; doi:10.1038/nature12415
Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer’s disease.
Dukart, J., Mueller, K., Villringer, A., Kherif, F., Draganski, B., Frackowiak, R., & Schroeter, M. L.
2013; Journal Neuroimage: Clinical; vol. 3; pp. 84-94; doi:10.1016/j.nicl.2013.07.005
Effects of baseline CSF alpha-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer’s disease.
Mattsson, N., Insel, P., Tosun, D., Zhang, J., Jack Jr., C. R., Galasko, D., … Weiner, M.
2013; Journal PloS One; vol. 8; no. 12; pp. e85443; doi:10.1371/journal.pone.0085443